heme has been researched along with Dysmyelopoietic Syndromes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Matary, Y; Dugas, M; Frank, D; Khandanpour, C; Liu, L; Nimmagadda, SC; Patnana, PK; Schütte, J; Varghese, J; Wei, L; Xie, X | 1 |
| Bergot, T; Bernard, DG; Bianchi, K; Bonnet, D; Cross, M; D'Alessandro, A; Di Bella, D; Finch, AJ; Gallipoli, P; Gribben, JG; Kordasti, S; Kubasch, AS; Maniati, E; Mian, SA; Morales, V; Nemkov, T; Philippe, C; Piganeau, M; Platzbecker, U; Protopapa, P; Rouault-Pierre, K; Wang, J; Wiseman, DH | 1 |
| Abkowitz, JL; Doty, RT; Lausted, CG; Meng, C; Munday, AD; Tian, Q; Yan, X; Yang, Z | 1 |
| Fujiwara, T | 1 |
| Åkerström, B; Flygare, J; Gram, M; Hansson, SR; Kristiansson, A; Storry, JR | 1 |
| Abkowitz, JL; Gerds, AT; Keel, SB; Li, HY; Liu, L; Scott, BL; Shimamura, A; Wood, BL; Yang, Z | 1 |
| Chalevelakis, G; Yalouris, AG | 1 |
| Ferrini, PR; Santini, V | 1 |
| Alcindor, T; Bridges, KR | 1 |
| Kauma, H; Timonen, TT | 1 |
| Tenhunen, R | 1 |
| Knuutila, S; Ruutu, T; Tenhunen, R; Volin, L | 1 |
| Hast, R | 1 |
| Ruutu, T; Tenhunen, R; Volin, L | 1 |
6 review(s) available for heme and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
[Ring sideroblasts and iron metabolism].
Topics: Anemia, Sideroblastic; Erythroid Precursor Cells; Heme; Humans; Iron; Mutation; Myelodysplastic Syndromes | 2020 |
The Role of α
Topics: Alpha-Globulins; Animals; Erythrocytes; Erythropoiesis; Female; Heme; Hemolysis; Homeostasis; Humans; Mice; Mice, Knockout; Myelodysplastic Syndromes | 2020 |
Differentiation therapy of myelodysplastic syndromes: fact or fiction?
Topics: Acetamides; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Azacitidine; Butyrates; Cholecalciferol; Cytarabine; Harringtonines; Hematopoietic Cell Growth Factors; Heme; Homoharringtonine; Humans; Interferons; Myelodysplastic Syndromes; Retinoids | 1998 |
Sideroblastic anaemias.
Topics: Anemia, Sideroblastic; Anti-Bacterial Agents; Chelating Agents; Chloramphenicol; DNA, Mitochondrial; Drug Overdose; Ethanol; Genes, Dominant; Genes, Recessive; Genetic Linkage; Heme; Humans; Iron; Myelodysplastic Syndromes; Vitamin B 6 Deficiency; X Chromosome | 2002 |
Heme in the treatment of heme deficiency states.
Topics: Anemia, Sideroblastic; Heme; Humans; Myelodysplastic Syndromes; Porphyrias | 1990 |
Sideroblasts in myelodysplasia: their nature and clinical significance.
Topics: Anemia, Sideroblastic; Bone Marrow; Erythrocytes; Erythropoiesis; Ferritins; Heme; Humans; Iron; Mitochondria; Myelodysplastic Syndromes; Prognosis | 1986 |
8 other study(ies) available for heme and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS).
Topics: Animals; Curcumin; Disease-Free Survival; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Heme; Leukemia, Myeloid, Acute; Mice; Mice, Transgenic; Myelodysplastic Syndromes; Promoter Regions, Genetic; Transcription Factors | 2021 |
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in
Topics: Anemia; Erythropoiesis; Heme; Humans; Myelodysplastic Syndromes; Pantothenic Acid; Phosphoproteins; Quality of Life; RNA Splicing Factors; Transcription Factors | 2023 |
The transcriptomic landscape of normal and ineffective erythropoiesis at single-cell resolution.
Topics: Anemia; Anemia, Diamond-Blackfan; Chromosome Deletion; Erythropoiesis; Heme; Humans; Myelodysplastic Syndromes; Ribosomal Proteins; Transcriptome | 2023 |
Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome.
Topics: Adult; Anemia; Anemia, Diamond-Blackfan; Anemia, Macrocytic; Erythroid Cells; Erythropoiesis; Female; Flow Cytometry; Globins; Heme; Humans; Myelodysplastic Syndromes; Reactive Oxygen Species | 2016 |
Haem administration in myelodysplastic syndromes: a possible mechanism of action.
Topics: alpha-Thalassemia; Arginine; beta-Thalassemia; Globins; Heme; Humans; Myelodysplastic Syndromes; Reticulocytes | 1993 |
Therapeutic effect of heme arginate in myelodysplastic syndromes.
Topics: Adult; Aged; Alanine Transaminase; Arginine; Aspartate Aminotransferases; Bone Marrow; Creatinine; Erythropoietin; Female; Heme; Humans; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes | 1992 |
Heme arginate treatment for myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Blood Cell Count; Female; Heme; Humans; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes | 1988 |
Haem arginate as a treatment for myelodysplastic syndromes.
Topics: Adult; Aged; Arginine; Bone Marrow; Female; Heme; Hemoglobins; Humans; Infusions, Intravenous; Leukocyte Count; Male; Myelodysplastic Syndromes; Neutrophils; Platelet Count | 1987 |